Bruker BRKR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bsi Biospin | $868.5M-1.2% | $878.8M-0.6% | $884.2M-2.7% | $908.5M-2.4% | $930.7M+2.8% | |
| Bsi Calid | $1.25B+3.0% | $1.21B+0.9% | $1.2B+2.9% | $1.17B+1.8% | $1.15B+4.8% | |
| Bsi Nano | $1.07B-1.0% | $1.08B-0.8% | $1.09B-1.8% | $1.11B0.0% | $1.11B+1.5% | |
| Energy And Supercon Technologies | $278.4M+2.8% | $270.9M-0.2% | $271.5M+1.9% | $266.4M-1.0% | $269.2M-4.9% | |
| Cost Of Segment Revenue by Business | ||||||
| Bsi Biospin | $458.9M-1.5% | $465.9M+2.8% | $453.3M-0.5% | $455.6M-0.6% | $458.3M+4.7% | |
| Bsi Calid | $546.7M+4.1% | $525.2M+2.5% | $512.3M+1.7% | $503.5M+2.9% | $489.4M+5.2% | |
| Bsi Nano | $525.3M+0.2% | $524M+0.3% | $522.6M-1.3% | $529.6M+1.1% | $523.8M+0.9% | |
| Energy And Supercon Technologies | $224.6M+2.8% | $218.5M+0.9% | $216.6M+2.8% | $210.7M+0.1% | $210.4M-5.4% | |
| Operating Income by Business | ||||||
| Bsi Biospin | $148.2M-5.3% | $156.5M-9.1% | $172.1M-12.0% | $195.6M-10.7% | $219.1M+1.2% | |
| Bsi Calid | $263.6M+0.4% | $262.5M-2.3% | $268.8M+6.9% | $251.5M-2.0% | $256.6M+4.2% | |
| Bsi Nano | $92.4M-8.6% | $101.1M+1.0% | $100.1M-6.6% | $107.2M-8.4% | $117M-5.4% | |
| Energy And Supercon Technologies | $27.3M+2.2% | $26.7M-10.4% | $29.8M-2.3% | $30.5M-10.0% | $33.9M-3.4% | |
| Selling General And Administrative Expense by Business | ||||||
| Bsi Biospin | $165.5M+1.7% | $162.7M-1.5% | $165.1M+1.0% | $163.5M+1.6% | $160.9M+1.3% | |
| Bsi Calid | $311.2M+2.8% | $302.8M+1.2% | $299.1M+2.0% | $293.3M+2.8% | $285.3M+5.6% | |
| Bsi Nano | $283.2M-0.3% | $284M-2.7% | $291.8M-2.1% | $298.1M+0.3% | $297.2M+2.2% | |
| Energy And Supercon Technologies | $22.9M+2.7% | $22.3M+2.3% | $21.8M+0.9% | $21.6M+2.4% | $21.1M-1.9% | |
| Total Assets by Business | ||||||
| BSI Bio Spin CALIDNANO And Corporate | $24.55B+0.9% | $24.34B+1.9% | $23.9B— | —— | —— | |
| Energy And Supercon Technologies | $769.6M-1.3% | $779.8M-0.9% | $787.2M-0.8% | $793.8M+1.5% | $782M+3.2% | |
| Segment Expenditure Addition To Long Lived Assets by Business | ||||||
| Bsi Biospin | $10.6M-7.0% | $11.4M-30.1% | $16.3M-34.5% | $24.9M-5.7% | $26.4M+15.8% | |
| Bsi Calid | $23.6M-6.7% | $25.3M-31.3% | $36.8M+1.7% | $36.2M-2.4% | $37.1M+9.1% | |
| Bsi Nano | $36.5M0.0% | $36.5M+39.8% | $26.1M-4.4% | $27.3M+50.8% | $18.1M-6.7% | |
| Corporate | $13.6M-15.0% | $16M-4.8% | $16.8M-13.8% | $19.5M+17.5% | $16.6M+13.7% | |
| Energy And Supercon Technologies | $10.6M-23.2% | $13.8M-11.5% | $15.6M-11.9% | $17.7M-18.1% | $21.6M-11.5% | |
| Research And Development Expense by Business | ||||||
| Bsi Biospin | $95.9M+2.3% | $93.7M+0.1% | $93.6M-0.2% | $93.8M+1.5% | $92.4M-0.1% | |
| Bsi Calid | $124.9M+4.3% | $119.7M+0.6% | $119M+1.2% | $117.6M+2.8% | $114.4M+2.4% | |
| Bsi Nano | $172.8M-1.4% | $175.2M-2.1% | $179M-0.1% | $179.2M+1.5% | $176.5M+7.1% | |
| Energy And Supercon Technologies | $3.6M+5.9% | $3.4M+3.0% | $3.3M-8.3% | $3.6M-5.3% | $3.8M-2.6% | |
| Restructuring Charges by Business | ||||||
| Bsi Biospin | $6.1M-32.2% | $9M+57.9% | $5.7M+21.3% | $4.7M-36.5% | $7.4M+363% | |
| Bsi Calid | $20M+1.5% | $19.7M+13.9% | $17.3M+215% | $5.5M+34.1% | $4.1M+41.4% | |
| Bsi Nano | $20.5M+57.7% | $13M+18.2% | $11M+57.1% | $7M-4.1% | $7.3M-28.4% | |
| Corporate | $3.4M+6.3% | $3.2M+191% | $1.1M-8.3% | $1.2M— | $0-100% | |
| D&A by Business | ||||||
| Bsi Biospin | $44.5M+3.0% | $43.2M-0.2% | $43.3M-1.6% | $44M+1.9% | $43.2M+5.4% | |
| Bsi Calid | $97.1M+5.2% | $92.3M+2.6% | $90M+5.8% | $85.1M+10.4% | $77.1M+14.9% | |
| Bsi Nano | $67.5M+0.4% | $67.2M+2.1% | $65.8M-0.6% | $66.2M+1.8% | $65M+5.3% | |
| Corporate | $9.2M+12.2% | $8.2M+17.1% | $7M+11.1% | $6.3M+12.5% | $5.6M+1.8% | |
| Energy And Supercon Technologies | $9.9M+5.3% | $9.4M+4.4% | $9M+2.3% | $8.8M+3.5% | $8.5M+1.2% | |
| Revenue by Product | ||||||
| Product And Service Other | $689M+2.8% | $670.1M+1.3% | $661.2M+2.2% | $646.9M+2.6% | $630.5M+3.8% | |
| Product | $2.77B+0.1% | $2.77B-0.4% | $2.78B-0.7% | $2.8B-0.7% | $2.82B+2.0% | |
| Cost Of Revenue by Product | ||||||
| Product And Service Other | $380.4M+2.2% | $372.3M+2.8% | $362.2M-1.1% | $366.4M+0.9% | $363.1M+3.0% | |
| Product | $1.51B+1.7% | $1.49B+2.2% | $1.45B+2.8% | $1.42B+1.4% | $1.4B+2.2% | |
| Revenue by Geography | ||||||
| Asia Pacific Excluding China | $555.9M+0.6% | $552.6M-0.2% | $553.7M-1.8% | $564.1M+3.9% | $542.9M+4.7% | |
| CN | $448.6M-5.7% | $475.8M+5.4% | $451.5M+0.1% | $451M-1.2% | $456.7M-3.1% | |
| DE | $298.6M+0.5% | $297M+7.0% | $277.6M-1.1% | $280.6M-8.0% | $305M-1.8% | |
| Europe Excluding Germany | $985M+3.7% | $950.2M-1.6% | $965.7M+2.7% | $940.1M+2.3% | $919M+5.3% | |
| Other Country | $274.6M+1.9% | $269.6M+2.5% | $263.1M-1.3% | $266.7M+2.0% | $261.4M+2.7% | |
| US | $895.8M+0.5% | $891.3M-3.9% | $927.3M-1.4% | $940.3M-2.2% | $961.1M+2.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bruker break its business down?
- Bruker (BRKR) reports revenue by business across 4 parts — Bsi Biospin, Bsi Calid, Bsi Nano and Energy And Supercon Technologies. Each is extracted from the segment footnotes and tracked over time.
- Where does Bruker's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bruker's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
